Fortress Biotech Inc.

NASDAQ: FBIOP · Real-Time Price · USD
6.60
-0.01 (-0.15%)
At close: May 05, 2025, 3:46 PM
6.60
0.00%
After-hours: May 05, 2025, 04:00 PM EDT
-0.15%
Bid 6.4
Market Cap 54.03M
Revenue (ttm) 57.67M
Net Income (ttm) -48.31M
EPS (ttm) -0.863
PE Ratio (ttm) -7.65
Forward PE n/a
Analyst n/a
Ask 6.7
Volume 7,461
Avg. Volume (20D) 12,845
Open 6.50
Previous Close 6.61
Day's Range 6.36 - 6.61
52-Week Range 4.72 - 17.45
Beta 1.83

About FBIOP

Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules...

Industry Biotechnology
Sector Healthcare
IPO Date Nov 14, 2017
Employees 101
Stock Exchange NASDAQ
Ticker Symbol FBIOP
Full Company Profile